JP2006519023A5 - - Google Patents

Download PDF

Info

Publication number
JP2006519023A5
JP2006519023A5 JP2006504501A JP2006504501A JP2006519023A5 JP 2006519023 A5 JP2006519023 A5 JP 2006519023A5 JP 2006504501 A JP2006504501 A JP 2006504501A JP 2006504501 A JP2006504501 A JP 2006504501A JP 2006519023 A5 JP2006519023 A5 JP 2006519023A5
Authority
JP
Japan
Prior art keywords
medium
virus
culture medium
fresh
protease
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2006504501A
Other languages
English (en)
Japanese (ja)
Other versions
JP2006519023A (ja
JP4787739B2 (ja
Filing date
Publication date
Priority claimed from GBGB0304799.0A external-priority patent/GB0304799D0/en
Application filed filed Critical
Publication of JP2006519023A publication Critical patent/JP2006519023A/ja
Publication of JP2006519023A5 publication Critical patent/JP2006519023A5/ja
Application granted granted Critical
Publication of JP4787739B2 publication Critical patent/JP4787739B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2006504501A 2003-03-03 2004-03-01 動物を含まない細胞培養方法 Expired - Fee Related JP4787739B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0304799.0A GB0304799D0 (en) 2003-03-03 2003-03-03 Novel method
GB0304799.0 2003-03-03
PCT/EP2004/002067 WO2004078955A1 (en) 2003-03-03 2004-03-01 Animal-free cell culture method

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2010157682A Division JP2010273683A (ja) 2003-03-03 2010-07-12 動物を含まない細胞培養方法

Publications (3)

Publication Number Publication Date
JP2006519023A JP2006519023A (ja) 2006-08-24
JP2006519023A5 true JP2006519023A5 (https=) 2007-04-19
JP4787739B2 JP4787739B2 (ja) 2011-10-05

Family

ID=9953995

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2006504501A Expired - Fee Related JP4787739B2 (ja) 2003-03-03 2004-03-01 動物を含まない細胞培養方法
JP2010157682A Pending JP2010273683A (ja) 2003-03-03 2010-07-12 動物を含まない細胞培養方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2010157682A Pending JP2010273683A (ja) 2003-03-03 2010-07-12 動物を含まない細胞培養方法

Country Status (17)

Country Link
US (1) US8034617B2 (https=)
EP (3) EP2186885A1 (https=)
JP (2) JP4787739B2 (https=)
KR (1) KR101242090B1 (https=)
CN (2) CN1756837B (https=)
AU (1) AU2004217807B2 (https=)
BR (1) BRPI0407636A (https=)
CA (1) CA2517327A1 (https=)
CO (1) CO5601047A2 (https=)
GB (1) GB0304799D0 (https=)
IS (1) IS7992A (https=)
MA (1) MA27631A1 (https=)
MX (1) MXPA05009096A (https=)
NO (1) NO20054124L (https=)
NZ (1) NZ541908A (https=)
RU (1) RU2369634C2 (https=)
WO (1) WO2004078955A1 (https=)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2396689T3 (es) 2003-12-11 2013-02-25 Isto Technologies Inc. Sistema de cartílago particulado
JP4650798B2 (ja) 2004-04-19 2011-03-16 デンカ生研株式会社 ウイルスの生産方法
AU2005302516A1 (en) * 2004-10-29 2006-05-11 Centocor, Inc. Chemically defined media compositions
JP4693839B2 (ja) * 2005-03-10 2011-06-01 共立製薬株式会社 動物由来の成分なしで培養可能である細胞株及びその作出方法、これを用いたウイルスの生産方法、及びワクチンの生産方法
JP2008541746A (ja) * 2005-06-03 2008-11-27 ビオヴィトルム・アクチボラゲット(プブリクト) 新規プロセス
EP1916964A4 (en) 2005-08-26 2015-11-04 Zimmer Inc IMPLANTS AND METHODS FOR THE REPAIR, REPLACEMENT AND TREATMENT OF JOINT DISEASES
EP1764117A1 (en) 2005-09-20 2007-03-21 Zimmer GmbH Implant for the repair of a cartilage defect and method for manufacturing the implant
US8163549B2 (en) 2006-12-20 2012-04-24 Zimmer Orthobiologics, Inc. Method of obtaining viable small tissue particles and use for tissue repair
AU2008240191B2 (en) 2007-04-12 2013-09-19 Zimmer, Inc. Compositions and methods for tissue repair
FI20075417A0 (fi) * 2007-06-05 2007-06-05 Marjo-Riitta Suuronen Koostumuksia ja menetelmiä alkion kantasolujen kasvatukseen
KR101594046B1 (ko) 2008-01-09 2016-02-15 첼카 게엠베하 개선된 배양 배지 첨가제 및 이를 이용한 방법
PE20110992A1 (es) 2009-02-17 2012-02-12 Glaxosmithkline Biolog Sa Composicion inmunogenica que comprende un antigeno del virus del dengue
CA2797356C (en) * 2010-04-26 2020-12-29 Novartis Ag Improved cell culture medium
CN101831415B (zh) * 2010-05-12 2012-05-30 江苏博立生物制品有限公司 一种提高糖化酶发酵水平的方法
DK2681306T3 (en) * 2011-02-28 2019-04-23 Harvard College CELL CULTURE SYSTEM
PT2788009T (pt) 2011-12-08 2016-08-31 Yeda Res & Dev Células pulmonares fetais de mamíferos e uso terapêutico das mesmas
US9493744B2 (en) * 2012-06-20 2016-11-15 Genentech, Inc. Methods for viral inactivation and other adventitious agents
US20130281355A1 (en) * 2012-04-24 2013-10-24 Genentech, Inc. Cell culture compositions and methods for polypeptide production
JP6041199B2 (ja) * 2012-09-14 2016-12-07 国立大学法人大阪大学 三次元細胞培養体の製造方法
US20140178343A1 (en) 2012-12-21 2014-06-26 Jian Q. Yao Supports and methods for promoting integration of cartilage tissue explants
EP4026563B1 (en) 2015-06-18 2025-10-29 Yeda Research and Development Co. Ltd Conditioning protocols and use of same for tissue regeneration
US10004795B2 (en) * 2015-09-08 2018-06-26 Fundacao Butantan Process for preparing an attenuated tetravalent dengue vaccine
BE1024160B9 (fr) 2015-12-22 2017-12-06 Glaxosmithkline Biologicals Sa Formulation immunogène
CN105567628B (zh) * 2016-01-30 2019-07-12 令世鑫 一种全悬浮培养mdck细胞的低血清培养基
CN105779376B (zh) * 2016-03-24 2019-08-30 友康恒业生物科技(北京)有限公司 一种流感病毒分离无血清培养基及其用途和制备
CN105695393B (zh) * 2016-03-24 2019-09-10 友康恒业生物科技(北京)有限公司 一种mdck细胞无血清培养基及其用途和制备
KR101925079B1 (ko) * 2017-05-24 2018-12-04 가천대학교 산학협력단 Dna 정제-증폭을 위한 통합형 마이크로 디바이스 및 이를 이용한 dna 정제-증폭 방법
CN107432931B (zh) * 2017-08-03 2018-04-13 长春祈健生物制品有限公司 一种微载体培养水痘病毒制备疫苗的方法
MX2021006115A (es) 2019-01-17 2021-07-07 Boehringer Ingelheim Animal Health Usa Inc Medio libre de suero para produccion de vacuna aviar y usos del mismo.
KR20220123019A (ko) 2019-12-31 2022-09-05 에어 프로틴 인코포레이티드 고단백질 식품 조성물
EP4093848A4 (en) * 2020-01-24 2024-08-07 Air Protein, Inc. Microorganism-derived protein hydrolysates, and methods of preparation and use thereof
CN113373107B (zh) * 2021-01-29 2022-12-30 上海生物制品研究所有限责任公司 一种大规模制备传代鸡胚细胞生产病毒的方法
WO2024039216A1 (ko) * 2022-08-19 2024-02-22 셀미트주식회사 동물세포 또는 동물 세포주의 배양방법
CN115627255B (zh) * 2022-12-01 2023-04-07 天信和(苏州)生物科技有限公司 一种采用低血清培养基培养人二倍体细胞的方法
KR102926380B1 (ko) * 2025-02-19 2026-02-12 (주)엑셀세라퓨틱스 줄기세포 유래 엑소좀의 제조방법, 엑소좀 및 이를 포함하는 조성물
CN119979445B (zh) * 2025-04-10 2025-09-09 四川大学 一种培养基、口腔黏膜上皮细胞模型,及其制备方法和用途

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL94611A (en) * 1989-06-05 1994-12-29 Organogenesis Inc Medium for cell cultures containing insulin or growth factor similar to insulin, transferrin or iron ion, triiodothyronine or thyroxine and method of use
GB9022545D0 (en) 1990-10-17 1990-11-28 Wellcome Found Culture medium
DE4115722A1 (de) 1991-05-14 1992-11-19 Boehringer Mannheim Gmbh Serumfreies medium zur kultivierung von saeugerzellen
RU2057176C1 (ru) * 1992-05-20 1996-03-27 Институт генетики АН Республики Молдова Питательная среда для культивирования клеток человека и животных
DZ1706A1 (fr) * 1992-08-07 2002-02-17 Merck & Co Inc Vaccin contre le virus de l'hepatite a.
EP0666751B1 (en) 1992-09-18 2001-09-12 SMITHKLINE BEECHAM BIOLOGICALS s.a. Mutants of hepatitis a virus strain hm-175 for use as hepatitis a vaccines
CN1088984A (zh) * 1993-11-11 1994-07-06 江西省医学科学研究所 一种用于造血祖细胞培养的无血清培养基
HRP950097A2 (en) 1994-03-08 1997-06-30 Merck & Co Inc Hepatitis a virus culture process
CA2205015C (en) 1994-11-10 2003-04-08 Otfried Kistner Method for producing biologicals in protein-free culture
WO1998000521A1 (fr) * 1996-06-28 1998-01-08 The Green Cross Corporation Milieux exempts de serum, methode de culture de cellules d'origine animale, et procede de production de substances physiologiquement actives
WO1998004680A1 (en) * 1996-07-26 1998-02-05 University Of Manitoba Serum-free medium for growth of anchorage-dependant mammalian cells
US6103529A (en) * 1996-10-10 2000-08-15 Life Technologies, Inc. Animal cell culture media comprising peptides derived from rice
WO1998059035A2 (en) * 1997-06-25 1998-12-30 The Goverment Of The United States Of America, Represented By The Secretary, Dept. Of Health And Human Services, National Institutes Of Health Serum-free cell growth medium
US6656719B1 (en) * 1997-10-27 2003-12-02 Merck & Co., Inc. Serum-free, low-protein media for rotavirus vaccine production
FR2775983B1 (fr) 1998-03-13 2000-11-10 Pasteur Merieux Serums Vacc Milieu et procede de propagation et de multiplication virales
WO1999057246A1 (en) * 1998-05-01 1999-11-11 Life Technologies, Inc. Animal cell culture media comprising non-animal or plant-derived nutrients
US6406909B1 (en) 1998-07-10 2002-06-18 Chugai Seiyaku Kabushiki Kaisha Serum-free medium for culturing animal cells
US6623959B2 (en) * 2001-06-13 2003-09-23 Ethicon, Inc. Devices and methods for cell harvesting

Similar Documents

Publication Publication Date Title
JP2006519023A5 (https=)
RU2005125606A (ru) Способ культивирования клеток без компонентов животного происхождения
KR100797547B1 (ko) 무혈청 배양 및 부유 배양에서 사용할 수 있는 세포 및상기 세포를 사용하여 백신용 바이러스를 제조하는 방법
RU2314344C2 (ru) Способ крупномасштабного производства вирусного антигена
JP5485863B2 (ja) 細胞を培養するための動物性タンパク質非含有培地
JP2009034115A5 (https=)
CN100374552C (zh) 大规模生产甲型肝炎病毒的方法
US8389261B2 (en) Method of isolation and purification of trypsin from pronase protease and use thereof
HU9202009D0 (en) Matrix with adherently bound cells and method for producing viruses and antigens thereof
EP1739167A4 (en) PROCESS FOR VIRUS PRODUCTION
US20120077268A1 (en) Animal-free cell culture method
Kim et al. Large-scale culture of hepatitis A virus in human diploid MRC-5 cells and partial purification of the viral antigen for use as a vaccine
Mazurkova et al. Optimization of Reproduction Conditions of the Vaccine Cold-Adapted Recombinant Strains of Influenza Virus in Roller-Cultivated MDCK Cells
Brill¹ et al. 4Cell® Nutrivero™ Flex 10 Medium–Impact of a Chemically Defined Medium on Vero Cells Growth and Productivity Essential in Vaccine Manufacturing
Mazurkova et al. Use of Plant-Derived Protease to Design of Live Cultural Influenza Vaccine